第一单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.;Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital, Boston, Massachusetts.
作者：
Edward R Scheffer,Cliff [1]
;
Guido D,Pelaez [2]
;
Fei,Wan [3]
;
Varun,Iyengar [4]
;
Jihao,Zhou [5]
;
Kevin,Chung [6]
;
Nayef,Abdel-Razeq [7]
;
Jessica,Allen [8]
;
Ajay,Major [8]
;
John,Sharp [9]
;
Narendranath,Epperla [10]
;
Patrick,Gould [11]
;
Hua-Jay J,Cherng [11]
;
Samin,Houshyar [12]
;
Danielle S,Wallace [12]
;
Ryan C,Lynch [13]
;
Avyakta,Kallam [14]
;
Matthew G,Mei [14]
;
Reid W,Merryman [15]
;
Michelle,Fleyshman [16]
;
Joanna M,Rhodes [16]
;
Adam,Kidwell [17]
;
Timothy S,Fenske [17]
;
Nikita,Malakhov [18]
;
Erin,Mulvey [18]
;
Marcus P,Watkins [19]
;
Muhamad,Alhaj Moustafa [7]
;
Talal,Hilal [6]
;
Grzegorz S,Nowakowski [5]
;
Yucai,Wang [5]
;
Pallawi,Torka [4]
;
David A,Russler-Germain [20]
作者单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.;Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital, Boston, Massachusetts.
[1]
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
[2]
Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri.
[3]
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
[4]
Division of Hematology, Mayo Clinic, Rochester, Minnesota.
[5]
Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.
[6]
Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida.
[7]
Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
[8]
Division of Hematology, Department of Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio.
[9]
Division of Hematology, Department of Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio.;Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
[10]
Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, New York.
[11]
Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
[12]
Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington.
[13]
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California.
[14]
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
[15]
Rutgers Cancer Institute, New Brunswick, New Jersey.
[16]
Medical College of Wisconsin, Milwaukee, Wisconsin.
[17]
Division of Hematology and Medical Oncology, Weill Department of Medicine, Weill Cornell Medicine, New York, New York.
[18]
Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
[19]
Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.;Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
[20]
DOI
10.1158/1078-0432.CCR-25-2392
PMID
41143601
发布时间
2026-03-11
换一批
